September 15, 2021 article Open access Structure-based classification predicts drug response in EGFR-mutant NSCLC Nature DOI: 10.1038/s41586-021-03898-1 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 493 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study 2025 Lung Cancer article Medicine Lung Cancer Treatments and Mutations Open access 2 citations A patient-centric knowledge graph approach to prioritize mutants for selective anti-cancer targeting 2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Bioinformatics and Genomic Networks Open access 0 citations Computational Characterization of Membrane Proteins as Anticancer Targets: Current Challenges and Opportunities 2024 International Journal of Molecular Sciences article Computer Science Computational Drug Discovery Methods Open access 3 citations EGFR stimulation enables IL-6 trans-signalling via iRhom2-dependent ADAM17 activation in mammary epithelial cells 2023 Biochimica et Biophysica Acta (BBA) - Molecular Cell Research article Medicine Cytokine Signaling Pathways and Interactions Open access 15 citations 4 results References 0